Vitamins A, B, C, D, E, and K as molecular modulators: Integrative roles in precision medicine, nutrigenomics, therapy, and disease prevention

Vitamins are no longer viewed just as essential micronutrients but as active molecular regulators that play a role in shaping health, disease susceptibility, and therapeutic outcomes. As cofactors, antioxidants, epigenetic modulators, and signaling molecules, vitamins coordinate key biochemical pathways that sustain cellular homeostasis and counteract metabolic, inflammatory, and degenerative processes. Molecular studies have indicated that Vitamins A, C, D, E, K, and the B-complex impact chromatin architecture, transcription factor binding, mitochondrial metabolism, and fine-tuning of the immune system. Through signaling cascades and gene networks such as Vitamin D receptor (VDR), retinoic acid receptor/RXR, Nrf2, ten–eleven translocation enzymes, and one-carbon metabolic pathways, vitamins control DNA methylation, oxidative balance, and cellular differentiation, thereby shaping precision disease prevention and personalized treatment responses. Progress in precision medicine and nutrigenomics further emphasizes gene–vitamin interactions that regulate individual variability in absorption, activation, and biological efficacy. Genetic variants in methylenetetrahydrofolate, VDR, SLC23A1, and SLC19A1 influence vitamin-dependent pathways and form the basis for biomarker-guided supplementation strategies. Multiomics platforms, including genomics, metabolomics, and single-cell profiling, now allow characterization of vitamin-sensitive molecular signatures across cardiovascular, neurodegenerative, metabolic, and oncological diseases. Targeted applications of vitamins – such as high-dose Vitamin D in immune dysfunction and oncology, high-dose Vitamin C in tumor redox modulation, and B vitamins in methylation disorders – establish promising therapeutic potential. Cutting-edge technologies, including artificial intelligence-driven risk forecasts and omics-integrated profiling, improve the precision of vitamin-based interventions. Comprehensively, these developments position vitamins as potent molecular modulators vital to modern preventive health strategies and personalized therapeutic frameworks, thus now shifting the paradigm toward disease prevention, targeted therapy, and improved clinical outcomes.

Institutions

Publication Details

Journal
Indian Journal of Precision Medicine and Molecular Medicine
Published
2025-05-01
DOI
https://doi.org/10.4103/ijpmmm.ijpmmm_10_25
Citations
1
Primary Topic
Vitamin C and Antioxidants Research
Type
article
Field-Weighted Citation Impact
1.12
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vitamins A, B, C, D, E, and K as molecular modulators: Integrative roles in precision medicine, nutrigenomics, therapy, and disease prevention

1 citations
Indian Journal of Precision Medicine and Molecular Medicine
Vitamin C and Antioxidants Research
1.12
article

Vitamins A, B, C, D, E, and K as molecular modulators: Integrative roles in precision medicine, nutrigenomics, therapy, and disease prevention

article en
1 citations

Abstract

Vitamins are no longer viewed just as essential micronutrients but as active molecular regulators that play a role in shaping health, disease susceptibility, and therapeutic outcomes. As cofactors, antioxidants, epigenetic modulators, and signaling molecules, vitamins coordinate key biochemical pathways that sustain cellular homeostasis and counteract metabolic, inflammatory, and degenerative processes. Molecular studies have indicated that Vitamins A, C, D, E, K, and the B-complex impact chromatin architecture, transcription factor binding, mitochondrial metabolism, and fine-tuning of the immune system. Through signaling cascades and gene networks such as Vitamin D receptor (VDR), retinoic acid receptor/RXR, Nrf2, ten–eleven translocation enzymes, and one-carbon metabolic pathways, vitamins control DNA methylation, oxidative balance, and cellular differentiation, thereby shaping precision disease prevention and personalized treatment responses. Progress in precision medicine and nutrigenomics further emphasizes gene–vitamin interactions that regulate individual variability in absorption, activation, and biological efficacy. Genetic variants in methylenetetrahydrofolate, VDR, SLC23A1, and SLC19A1 influence vitamin-dependent pathways and form the basis for biomarker-guided supplementation strategies. Multiomics platforms, including genomics, metabolomics, and single-cell profiling, now allow characterization of vitamin-sensitive molecular signatures across cardiovascular, neurodegenerative, metabolic, and oncological diseases. Targeted applications of vitamins – such as high-dose Vitamin D in immune dysfunction and oncology, high-dose Vitamin C in tumor redox modulation, and B vitamins in methylation disorders – establish promising therapeutic potential. Cutting-edge technologies, including artificial intelligence-driven risk forecasts and omics-integrated profiling, improve the precision of vitamin-based interventions. Comprehensively, these developments position vitamins as potent molecular modulators vital to modern preventive health strategies and personalized therapeutic frameworks, thus now shifting the paradigm toward disease prevention, targeted therapy, and improved clinical outcomes.

Indian Journal of Precision Medicine and Molecular MedicineVol. 1(2)
Galgotias University (IN), All India Institute of Medical Sciences (IN)
Zero hunger
Openalex Percentile: Top 17%
Vitamin C and Antioxidants Research
1.12
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.